avarol has been researched along with Leukemia L5178 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batke, E; Gasić, MJ; Hummel, K; Kallinowski, F; Müller, WE; Ogura, R; Schröder, HC; Vaupel, P | 1 |
| Becker, C; Diehl-Seifert, B; Dogovic, N; Gasic, MJ; Maidhof, A; Müller, WE; Sachsse, W; Schröder, HC; Zahn, RK | 1 |
2 other study(ies) available for avarol and Leukemia L5178
| Article | Year |
|---|---|
Action of the antileukemic and anti-HTLV-III (anti-HIV) agent avarol on the levels of superoxide dismutases and glutathione peroxidase activities in L5178y mouse lymphoma cells.
Topics: Animals; Antiviral Agents; Chromatography, High Pressure Liquid; Electron Spin Resonance Spectroscopy; Glucose; Glutathione Peroxidase; HIV; Hydrogen-Ion Concentration; Leukemia L5178; Leukemia, Experimental; Mice; Oxidation-Reduction; Sesquiterpenes; Superoxide Dismutase; Tumor Cells, Cultured | 1988 |
Inhibition of mitosis by avarol, a natural product isolated from the sponge Dysidea avara.
Topics: Animals; Cell Division; Chromosomes; Growth Inhibitors; Leukemia L5178; Mice; Microtubule Proteins; Mitosis; Mitotic Index; Porifera; Sesquiterpenes | 1985 |